Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Total Net Revenue $ 2,198,643 $ 1,464,016 $ 8,531,880 $ 6,043,374
Total Cost of Sales 1,333,588 949,911 5,264,366 3,447,356
Gross Profit 865,055 514,105 3,267,514 2,596,018
Operating Expenses:        
Research and development 448,690 539,652 1,360,986 1,410,287
Selling, general and administrative 1,137,084 1,248,204 3,936,851 3,816,210
Depreciation and amortization 16,775 16,797 50,750 50,340
Total Operating Expenses 1,602,549 1,804,653 5,348,587 5,276,837
Operating loss (737,494) (1,290,548) (2,081,073) (2,680,819)
Other Income (Expenses):        
Gain on fixed assets 150 0 150 0
Interest income (expense), net (16,525) 9,540 (37,125) 11,063
Total Other Income (Expense) (16,375) 9,540 (36,975) 11,063
Loss before Provision for Income Taxes (753,869) (1,281,008) (2,118,048) (2,669,756)
Provision for Income Taxes 0 0 0 2,000
Net Loss Attributable to Common Stockholders $ (753,869) $ (1,281,008) $ (2,118,048) $ (2,671,756)
Net Loss per Common Share:        
Basic - net loss attributable to common stockholders $ (0.01) $ (0.01) $ (0.02) $ (0.02)
Diluted - net loss attributable to common stockholders $ (0.01) $ (0.01) $ (0.02) $ (0.02)
Weighted Average Common Shares Outstanding- basic 135,331,951 133,989,919 134,937,277 133,892,730
Weighted Average Common Shares Outstanding - diluted 135,331,951 134,238,181 134,937,277 133,892,730
Product [Member]        
Total Net Revenue $ 1,995,788 $ 1,319,046 $ 7,963,349 $ 5,643,509
Total Cost of Sales 1,259,151 881,444 5,026,815 3,252,409
Recurring [Member]        
Total Net Revenue 202,855 144,970 568,531 399,865
Total Cost of Sales $ 74,437 $ 68,467 $ 237,551 $ 194,947